VCIM
STRO icon

Velan Capital Investment Management’s Sutro Biopharma STRO Stock Holding History

Velan Capital Investment Management’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17M Hold
512,160
– – 10.36% 3
2026
Q1 		$12.8M Buy
512,160
+200,160
+64% +$3.62M 7.99% 3
2025
Q4 		$3.61M Hold
312,000
– – 2.09% 16
2025
Q3 		$2.71M Buy
312,000
+6,000
+2% +$51.1K 2.54% 14
2025
Q2 		$2.18M Buy
306,000
+203,000
+197% +$1.66M 2.16% 15
2025
Q1 		$670K Buy
103,000
+100,000
+3,333% +$1.57M 0.69% 24
2024
Q4 		$55.2K Buy
+3,000
New +$91.6K 0.05% 36

Other funds holding STRO

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Velan Capital Investment Management's STRO Position: Q2 2026 in Review

Velan Capital Investment Management held its Sutro Biopharma (STRO) position steady in Q2 2026 at 512,160 shares worth $17M. The position accounts for 10.36% of the portfolio, ranked #3.

Velan Capital Investment Management first reported a position in STRO in Q4 2024 and has held it in 7 quarters since. 100 funds tracked by Wall St. Rank hold STRO as of Q2 2026.

  • Velan Capital Investment Management held 512,160 shares of Sutro Biopharma worth $17M as of Q2 2026.
  • Velan Capital Investment Management left its Sutro Biopharma share count unchanged in Q2 2026.
  • Sutro Biopharma made up 10.36% of Velan Capital Investment Management's portfolio in Q2 2026, its #3 holding.
  • Velan Capital Investment Management first reported a position in Sutro Biopharma in Q4 2024 and has held it in 7 quarters since.
  • 100 funds tracked by Wall St. Rank held Sutro Biopharma as of Q2 2026.

Based on Velan Capital Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.